Figure 1
![Figure 1. Time to event curves for patients in the phase 2 DRC study. (A) Overall survival (OS) according to age (≤65, 66 to 75, and 75 years). (B) WM-related and unrelated mortality. (C) OS per response category (including very good partial response [VGPR] category as per the revised response criteria published by Owen et al1). (D) Progression, and unrelated mortality without progression. CR, complete response; MR, minor response.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/126/11/10.1182_blood-2015-05-647420/4/1392f1.jpeg?Expires=1735545751&Signature=YDpOs7vD8LsGaGykarhHeKqdkit2wbA4WvPDWglhEnekVX-1kAM~ey~6EeBpWyUd9kZs6NSTPEKW6Em~5ooqhsCm9jSe6jYkVkWgJ8xV1OwNOEqGR8YLcCIC4EMSjNELdVqqczRmomi9q43iImiy3Eoq~48xpBQlTfj3xLEtYabXWks2uTOy0b~3KOxc7RzUx8mJXEv3VdbsgfbXqyIY5yUIZGD1e6cEuygaArNcHQ0gSK8SfIH7uh7Sc4AkoATTDtVEmZIv-o3f2vf~HX6162~SPF1buFRrRQa6sOcL7rrEEyo2c0LrP-jXRQzHVAtmYQqjvBu4xG3B1F-RSKcr1g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Time to event curves for patients in the phase 2 DRC study. (A) Overall survival (OS) according to age (≤65, 66 to 75, and 75 years). (B) WM-related and unrelated mortality. (C) OS per response category (including very good partial response [VGPR] category as per the revised response criteria published by Owen et al1 ). (D) Progression, and unrelated mortality without progression. CR, complete response; MR, minor response.
